Home
Storia in 1 fonti
Pharmalittle: We're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more
In this morning's Pharmalittle roundup, we're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more.
Raccontata da
statnews.com
Timeline cronologica
- ·
Pharmalittle: We're reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more
Eli Lilly reported that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a Phase 1 clinical trial
- ·
Pharmalittle: We're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more
In this morning's Pharmalittle roundup, we're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more.
- ·
Pharmalittle: We're reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
Pharma updates from the Pharmalot campus via the Pharmalittle newsletter